Search

ISSN: 2228-5881 eISSN: 2251-7308

Adv Pharm Bull. 2023;13(3): 408-410. doi: 10.34172/apb.2023.045

PMID: 37646061 PMCID: PMC10460798

Letter to Editor

Fluvoxamine Mediates Specific, Early, and Delayed SARS-CoV-2 Protection through Antioxidant and Cytoprotective Pathways via Sigma-1 Receptor Agonism

Konstantinos Papadopoulos ¹ * , Alexandra Papadopoulou ² , Tar Choon Aw ³

Cited by CrossRef: 0

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank